Valerio Therapeutics S.A.
ALVIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €12 | €22 | €29 | €24 |
| - Cash | €1 | €7 | €15 | €18 |
| + Debt | €13 | €9 | €10 | €10 |
| Enterprise Value | €24 | €25 | €24 | €16 |
| Revenue | €2 | €2 | €1 | €4 |
| % Growth | -0.4% | 24.7% | -64.5% | – |
| Gross Profit | €1 | €1 | €1 | €4 |
| % Margin | 71.4% | 70.4% | 64.4% | 90.9% |
| EBITDA | -€12 | -€18 | -€17 | -€6 |
| % Margin | -672.7% | -1,024.7% | -1,180.7% | -144.2% |
| Net Income | -€24 | -€20 | -€20 | -€6 |
| % Margin | -1,334.7% | -1,130.2% | -1,355.6% | -146.2% |
| EPS Diluted | -0.16 | -0.15 | -0.18 | -0.067 |
| % Growth | -6.7% | 16.7% | -167.5% | – |
| Operating Cash Flow | -€12 | -€19 | -€9 | -€9 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€13 | -€19 | -€10 | -€9 |